Senior insider sale
President and CEO at VIRIDIAN THERAPEUTICS, INC.\DE — senior position signals high conviction
$223.6K
7.41K shares
What this filing means
MAHONEY STEPHEN F. plans to sell 7.41K shares of VIRIDIAN THERAPEUTICS, INC.\DE valued at approximately $223.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001959173-26-001921
Officer· President and CEO
Since Mar 2026
7.41K
Shares to sell
$223.6K
Approx. market value
7.41K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/3/2026
7.41KTotal acquired7.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2026 | Restricted Stock Vesting Compensation | 7.41K | — |
| Total | 7.41K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.41K
Market value
$223.6K
3/4/2026
Total
Units
7.41K
Value
$223.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/4/2026 | 7.41K | $223.6K | NASDAQ | Planned |
| Total | 7.41K | $223.6K | ||